Sponsored by:
Prix Galien Russia 2013 AWARDS CEREMONY
DRAFT PROGRAM
19h-20h00 WELCOME COCKTAIL
20h00 DINNER AND AWARDS CEREMONY
Video presentation of Prix Galien Russia and Thank you to sponsors, partners, supporters
20h25: WELCOME REMARKS: French Ambassador
Opening Speech: Prix Galien Russia General Secretary
Words from the President of the Jury
20h35: Prix Galien Pro Bono Humanum Awards
Medal presented by President of the Jury + VIP
Acceptance speech by Prof. Alexander Rumantsyev
20h40: AWARDS CEREMONY
Keynote Address: H.E. Veronika Skvortsova, Minister of Health of RF
Best Research in Russia Presentation of Candidates
Medal presented by H.E. Minister of Health of Russia + VP of the Jury
Short Speech by jury member
Acceptance words by laureate
Best Biopharmaceutical Product Presentation of Candidates
Medal presented by member of the Jury + VIP
Short speech by jury member
Acceptance words by laureate
Best Pharmaceutical Agent Presentation of Candidates
Medal Presented by member of jury + VIP
Short Speech by jury about the laureate
Acceptance words by laureate
21h00: CLOSING REMARKS:
Florence Mehl General Secretary of Prix Galien International
Final Words: Alexey Komissarov - Moscow Government Minister and Head of the
Department of Science, Industrial Policy and Entrepreneurship
21h10: DESSERT PARTY and MUSICAL BREAK
Sponsored by:
THE PRIX GALIEN RUSSIA AWARDS For the first time, the Prix Galien Russia Awards will be bestowed in a gala award ceremony on October 24th 2013 in Moscow. Winners will be selected by a distinguished body of scientists. One winner will be announced in each of the following categories:
Best Therapeutic Research in Russia
Best Pharmaceutical Agent
Best Biotechnology Product
Selection Committee: Prof. Sergey Bachurin: Director of the Institute of Phisiologically Active Compounds of the Russian Academy of Science Prof. Alexander Chuchalin (President) – Director of Pulmonology Research Institute, Head of the Department of Hospital Therapy, Pediatric Faculty, Russian Medical State University Prof. Vladimir Ivashkin – President of Russian Gastroenterological Association Prof. Eugeny Nasonov – Director of Research Institute of Rheumatology of RAMS Prof. Rem Petrov – Academician Prof. Dmitry Pushkar – Chief Urologist Ministry of Health and Social development of the Russian Federation Prof. Gennady Sukhikh – Director FSI Obstetrics, Gynecology and Neonatology Research Institute Prof. Evgeny Sverdlov – Head of the Genetics and Postgenomic Technologies Dpt of the Shemyakin-Ovchinnikov Institute of Bioorganic Prof. Michael Ugrumov (vice-president) – Head of the Laboratory of Hormonal Regulations of the Institute of Developmental Biology of the RAS, Advisor to the President of RAS
Sponsored by:
The Prix Galien Award The Prix Galien was created in France in 1970 by a pharmacist named Roland Mehl. Its aim was to promote significant advances in pharmaceutical research. Until the creation of the Prix Galien, this field of research had remained largely unrecognized. A prominent jury was brought together, including clinicians, toxicologists, pharmacologists and pharmacists. Each year, the award has been an opportunity to give credit to the most important drugs introduced into the public market as well as to the achievements of the best research team in the pharmaceutical field. Since its creation, the Galien award has grown into a major event. It is seen as an influential event by all those interested in pharmaceutical research, including public authorities, scientists, pharmaceutical companies and medical press groups. For this reason, it is also considered as the industry’s equivalent of the Nobel Prize and the highest accolade for pharmaceutical research and development. Prix Galien Around the World The importance of the Prix Galien in France has led to similar initiatives in several other countries. The first countries other than France to create their own Galien award were Belgium and Luxemburg in 1982, followed in 1984 by Germany, and in 1985 by the Netherlands. In 1988 the United Kingdom created a Galien award, followed in 1989 by Italy, in 1990 by Spain, in 1992 by Portugal, in 1993 by Canada, in 2001 by Switzerland and in 2007 by the United States, in 2012, Poland, Israël, Greece and Singapore. In addition, a European Galien award was created in 1990 in Paris to reward one of the winners of the national Galien awards of the two previous years. This prize was also awarded in Brussels in 1992 and in Berlin in 1994. After Canada introduced its own prize, the European Galien award was turned into an International Galien award in 1996, in London. The 30th ceremony of the French prix Galien and the 5th ceremony of the International Galien award took place at Unesco on 10 February 1999. On this occasion, a prominent honorary committee was invited, including four Nobel laureates. Montreal organised the International Galien award in 2000, Madrid did so in 2002 and Lisbon in 2004, in Zurich in 2006. The 10th anniversary of the international prix Galien was awarded in Berlin in October 2008, in New York in 2010 and in Lyon in 2012. Israel will welcome the International Prix Galien in 2014.
Sponsored by:
Prix Galien Russia News
Minister of Health, Veronika Skvortsova to be Keynote Speaker at first
Prix Galien Russia Ceremony
October 09, 2013
The Prix Galien Russia Committee received confirmation that Veronika Skvortsova, Minister
of Health of the Russian Federation will be the keynote speaker at the Prix Galien Russia
2013 ceremony.
“It is an immense pleasure to receive such support from Prof. Skvortsova. Her presence at the
ceremony not only enhances the visibility of this important event, but it is also highly
symbolic for all candidates as Prof. Skvotsova is herself a scientist and a doctor who
understands well the value of therapeutic research.” Said Frédéric Boucheseiche, General
Secretary of Prix Galien Russia.
The Prix Galien Russia awards will honor companies and researchers who have made
innovative contributions to biopharmaceutical and medical technology research and
development. Prix Galien Russia 2013 will be held at the SwissÔtel Krasnye Holmy
Conference Center in Moscow on the 24th of October, 2013.
About Prix Galien Russia:
A Jury of eminent specialists involved in the sphere of Russian and international
pharmaceutical research will announce the laureates in three categories: Best Research in
Russia, Best Pharmaceutical Agent, Best Biopharmaceutical Product.
Around the world, the Prix Galien awards outstanding achievements in improving the global
human condition through the development of innovative therapies.
To attend or support the Prix Galien 2013 awards ceremony contact: Crystelle Coury
Sponsored by:
Dina Korzun, Chulpan Xhamatova and Alexander Rumyantsev selected as
2013 Pro Bono Humanum honorees by Prix Galien Russia
October 09, 2013
The Prix Galien Russia Committee, responsible for awarding the most prestigious prize in
biopharmaceutical research and development, announced today that Dina Korzun, Chulpan
Xhamatova and Alexander Rumyantsev of the “Gift of Life Charity Foundation” (Podari
Zhizn) will be awarded the 2013 Pro Bono Humanum Award during the 1st Annual Prix
Galien Russia Award Ceremony.
The Prix Galien Russia Committee selected this year’s laureate for their commendable actions
to offer hope and practical care to children and young adults whose families cannot afford
treatment for cancer, hematologic and other life-threatening illnesses. Their work has saved
the lives of dozens of children through the provision of vital medicine.
The Pro Bono Humanum Award is presented by the Prix Galien Russia Committee to
exemplary individuals, companies, academic institutions or non-governmental organizations
that have made innovative efforts to improve access to biopharmaceutical treatment for
underserved populations, and as such, improving the human condition.
This special award will be presented to Professor Alexander Rumantsyev, director of the
Federal Dmitry Rogachev Research Clinical Center of Children’s Hematology, chief
hematologist of the Russian Federation and Head of the Department of Pediatrics of the
Russian State Medical University, in the presence of the Prix Galien Russia selection
committee; H.E. Veronika Skortsova, Minister of Health of Russia and H.E. Jean de
Gliniasty, Ambassador of France to the Russian Federation.
The annual presentation of the Pro Bono Humanum Award accompanies a series of other
awards honoring companies and researchers who have made innovative contributions to
biopharmaceutical and medical technology research and development. Prix Galien Russia
2013 will be held at the SwissÔtel Krasnye Holmy Conference Center in Moscow on the 24th
of October, 2013.
About Prix Galien Russia:
The 2013 Prix Galien Russia ceremony will take place in Moscow on the 24th of October. A
jury of eminent specialists involved in the sphere of Russian and international pharmaceutical
research will announce the laureates in three categories: Best Therapeutic Research in Russia,
Best Pharmaceutical Agent and Best Biopharmaceutical Product.
Around the world, the Prix Galien awards outstanding achievements to improve the human
condition worldwide through the development of innovative medical therapies.
Sponsored by:
To attend or support the Prix Galien 2013 awards ceremony or sponsor opportunities, please
contact Crystelle Coury : [email protected]
Prof. Leonid Roshal, Dr. Yuri Kalinin and Prof. André Syrota are
designated honorary members of the Prix Galien Russia Committee
October 09, 2013
Frédéric Boucheseiche, General Secretary of Prix Galien Russia, announced today that
Professor Leonid Roshal, President of the National Medical Chamber of Russia, Doctor Yuri
Kalinin, President of “Rosmedprom” and Professor André Syrota, President of Inserm,
France’s most important public scientific and technological institute, have agreed to join the
Prix Galien Russia Committee as honorary members.
The General Secretary declared: “It is incredible to count with the support of such
personalities for the first edition of Prix Galien Russia. It shows that our initiative is not only
receiving great interest in Russia, but also abroad. Although their role is purely honorary, I am
sure that there presence on our board will greatly contribute to the future impact and
importance of Prix Galien in Russia.”
About Prix Galien Russia:
The 2013 Prix Galien Russia ceremony will take place in Moscow on the 24th of October. A
jury of eminent specialists involved in the sphere of Russian and international pharmaceutical
research will announce the laureates in three categories: Best Therapeutic Research in Russia,
Best Pharmaceutical Agent and Best Biopharmaceutical Product.
Around the world, the Prix Galien awards outstanding achievements to improve the human
condition worldwide through the development of innovative medical therapies.
To attend or support the Prix Galien 2013 awards ceremony or sponsor opportunities, please
contact Crystelle Coury : [email protected]
Prix Galien Russia Ceremony to be broadcast live on Internist.ru
October 09, 2013
Oxana Drapkina, Vice President of the Russian Internet Society for Internists:
(Национальное Интернет Общество специалистов по внутренним болезням) and
Frédéric Boucheseiche, General Secretary of Prix Galien Russia, are pleased to announce that
the first edition of Prix Galien Russia will be broadcast live on www.internist.ru .
Sponsored by:
“We are very happy to build a long term partnership with the Prix Galien Russia, as our
audience is very much interested in such important events. It is important that Russian doctors
and regional healthcare and medical scientific organizations, especially in the regions, are
fully aware about the Prix Galien Russia. We are already receiving many inquiries from the
regions and we expect an audience of around 8,000 doctors”, said Drapkina.
“The partnership with Internist.ru is very valuable, as it will allow doctors and scientists from
all over Russia and the CIS to be aware of Prix Galien while following the event live to
discover together with our audience the names of the laureates”, added Frédéric
Boucheseiche.
Already more than 170 guests have confirmed their presence at the first Prix Galien Russia
awards ceremony. The black-tie cocktail and gala dinner will take place at Moscow’s
SwissÔtel Krasnye Holmy Conference Center on the 24th of October 2013.
Other media and information partners of Prix Galien Russia are Cegedim,
PharmaBoardroom.com, Pharmaceutical Executive (USA), Ria Ami and Vademecum.
About Russian Internet Society for Internists:
The Russian Internet Society for Internists supports international education programs for
physicians around Eastern Europe, Russia and CIS. The Society is the educational TV
broadcast partner of the Russian Gastroenterology Association, the Russian Cardiology
Society and the Therapeutic Council of Russian Academy of Medical Sciences. It records and
broadcasts live selected sessions and symposiums of annual events of those bodies on the
website Internist.ru.
About Prix Galien Russia:
The 2013 Prix Galien Russia ceremony will take place in Moscow on the 24th of October. A
jury of eminent specialists involved in the sphere of Russian and international pharmaceutical
research will announce the laureates in three categories: Best Therapeutic Research in Russia,
Best Pharmaceutical Agent and Best Biopharmaceutical Product.
Around the world, the Prix Galien awards outstanding achievements to improve the human
condition worldwide through the development of innovative medical therapies.
To attend or support the Prix Galien 2013 awards ceremony or sponsor opportunities, please
contact Crystelle Coury: [email protected]
Sponsored by:
Prix Galien Russia 2013 receives broad industry support
October 04, 2013
Sponsors of the first edition of the Prix Galien Russia award ceremony include Aston
Consulting, E&Y, IMS, PharmaBoardroom.com, Santens Service and Technopolis Moscow.
Already more than 170 guests have confirmed their presence at the first Prix Galien Russia
awards ceremony. The black-tie cocktail and gala dinner will take place at Moscow’s
SwissÔtel Krasnye Holmy conference center on the 24th
of October 2013.
Laureates of three categories will be announced in the presence of the selection committee
and influential industry guests. Amongst the prominent figures attending the ceremony are
H.E. Veronika Skvortsova, Minister of Health of Russia and H.E. Jean de Gliniasty,
Ambassador of France to the Russian Federation. Representatives of the following companies
will also be present at the event: Abbott Diagnostics, Abbvie, Amgen, Arval (BNP Paribas
Group), Aston Consulting, Astra Zeneca, Baxter, Besins Healthcare, Bristol-Myers Squibb,
Boehringer Ingelheim , Cegedim, Chiesi, Deloitte, Ernst & Young, Ferring, F.Hoffmann-La
Roche Ltd., Generium, GFK, IMS, Janssen, Kuehne + Nagel, Lilly, Les Laboratoires Servier,
Mayoly Spindler, Merck Serono, Merz, Metamax, Mitotech, MSD Pharmaceuticals, Nova
Medica, Novartis, Novo Nordisk, Oncomax, Pfizer, Pharma Bio, Pharm-Syntez, PwC,
Quantum Pharma, R-Pharm, Santens Service, SAP, Skolkovo Foundation, Takeda,
Technopark Mosgormash, Technopolis Moscow, UCB…
About Prix Galien Russia:
The 2013 Prix Galien Russia ceremony will take place in Moscow on the 24th of October. A
jury of eminent specialists involved in the sphere of Russian and international pharmaceutical
research will announce the laureates in three categories: Best Therapeutic Research in Russia,
Best Pharmaceutical Agent and Best Biopharmaceutical Product.
Around the world, the Prix Galien awards outstanding achievements to improve the human
condition worldwide through the development of innovative medical therapies.
To attend or support the Prix Galien 2013 awards ceremony or sponsor opportunities, please
contact Crystelle Coury : [email protected]
Sponsored by:
Prix Galien Russia 2013 Nominees for “Best Research in Russia,” “Best
Pharmaceutical Agent” and “Best Biotechnology Product” announced.
Winners to be Recognized by Research and Academic Leaders at October
24th Award Ceremony in Moscow
August 01, 2013
Focus Reports, organizer of the Prix Galien Russia, today announced the 2013 nominees for
the first annual Prix Galien Russia Awards. The Prix Galien Award is considered the
biomedical industry’s highest accolade and recognizes the technical, scientific and clinical
research skills necessary to develop innovative medicines.
Nominees include research programs lead in Russia by companies and academic institutes and
biomedical products that advance the human condition and which were approved by the
Russian Ministry of Health during the past five years.
Nominees for the Prix Galien Russia 2013 Awards are:
Best Research in Russia (Nominees)
DIASKINTEST® CSJC “GENERIUM”
MM-D37K® Metamax Ltd
SkQ – mitochondrially targeted antioxidant (Visomitin ®) Mitotech LLC
OM-RCA-01® Oncomax Ltd
C12-OB® Pharma Bio LLC
Timodepressin® Pharma Bio LLC
Inhibitor of the HIV virus matrixprotein p17/MA® Quantum Pharmaceuticals LLC
Modular nanotransporters®
Russian Academy of Sciences
Professor Alexander S. Sobolev,
Head, Laboratory of Molecular
Genetics of Intracellular Transport
Institute of Gene Biology
Best Pharmaceutical Agent (Nominees)
TICAGRELOR (BRILINTA®) AstraZeneca
Sponsored by:
Sorafenib (Nexavar ®) Bayer HealthCare
Iloprost (Ventavis ®) Bayer HealthCare
Rivaroxaban (Xarelto ®) Bayer HealthCare
Ethinylestradiol + Drospirenone + Levomefolate
Calcium (Yaz Plus ®)
Bayer HealthCare
Estradiol Valerate (Qlaira ®) Bayer HealthCare
Dienogest (Visanne ®) Bayer HealthCare
Dabigatran etexilat (Pradaxa®) Boehringer Ingelheim
Telaprevir (INCIVO ®) JANSSEN
Abiraterone (ZYTIGA ®) JANSSEN
Pemetrexed (Alimta®) Eli Lilly
Sitagliptin+metformin (Janumet ®) MSD Pharmaceuticals
Raltegravir (Isentress ®) MSD Pharmaceuticals
Everolimus (Afinitor ®) Novartis Pharma
Vildagliptin (Galvus ®) Novartis Pharma
Fingolimod (Gilenya ®) Novartis Pharma
Nilotinib (Tasigna ®) Novartis Pharma
Agomelatine (Valdoxan ®) Les Laboratoires Servier
IVABRADINE (Coraxan ®) Les Laboratoires Servier
Roflumilast (Daxas ®) Takeda
Best Biotechnology Product (Nominees)
Adalimumab (Humira®) AbbVie
Denosumab (Xgeva®) Amgen
Sponsored by:
Abatacept (ORENCIA®) Bristol-Myers Squibb
Teriparatide (Forsteo®) Eli Lilly
Cetuximab (Erbitux®) Merck Serono, division of Merck
Epoetin alfa (Binocrit®) Sandoz
Canakinumab (Ilaris®) Novartis Pharma
ranibizumab (Lucentis®) Novartis Pharma
Tocilizumab (ACTEMRA®) F.Hoffmann-La Roche Ltd.
The Prix Galien Russia Committee comprised of nine renowned leaders in biomedical
research is responsible for evaluating nominees. Winners will be honored at the Prix Galien
Russia Award Ceremony in the SwissÔtel convention center, on the 24th of October 2013.
“This first Edition of the Prix Galien Russia can already be considered a success, looking at
the number and variety of candidates and the quality of the Jury”, remarked Frédéric
Boucheseiche, General Secretary of the Prix Galien Russia. “We are proud to honor those that
drive progress in medical science and improve human condition through their innovations,
research efforts and dedication.”
About Prix Galien Russia:
The Prix Galien Russia will be inaugurated in Moscow, Russia in 2013 under the auspice of
an exceptional awards committee composed of eminent specialists involved in the sphere of
Russian and international pharmaceutical research.
Around the world, the Prix Galien awards outstanding achievements in improving the global
human condition through the development of innovative therapies.
To attend or support the Prix Galien 2013 awards ceremony or sponsor opportunities, please
contact Crystelle Coury : [email protected]
Sponsored by:
Deadline for Prix Galien – Research in Russia extended
June 28, 2013
The Prix Galien Russia General Secretary announced today that the deadlines for participation
in the Prix Galien - Research in Russia Special Prize are extended to July 15th (to officially
confirm participation and return the booking form) and July 30th (to submit the application
files).
As a reminder, the Research in Russia Special Prize is open to academia, healthcare
institutions, research centers, and companies that have been involved in bio-pharmaceutical
research in Russia for at least three years. Applicants must demonstrate a substantial
contribution to the diagnosis, prevention, or treatment of disease.
The first Prix Galien Russia medals will be awarded in three categories during an exclusive
Gala Dinner ceremony on the 24th
of October 2013 at the SwissÔtel Moscow Convention
center.
To apply or recommend candidates for the Special Prize, attend the Gala dinner, become a
sponsor, or for further enquiries about Prix Galien Russia, please contact Crystelle Coury
at [email protected] or on this site.
First Prix Galien Russia generates great interest
June 14, 2013
AbbVie, Amgen, AstraZeneca, Bayer, BMS, Boehringer Ingelheim, Janssen, Lilly, Merck,
MSD, Novartis, Roche, Servier, and Takeda will all submit one or more products in the Best
Pharmaceutical Agent and/or Best Biotechnological Product categories of the competition.
Applications in those two categories are now closed.
With 14 multinational biopharmaceutical companies confirming their participation with a
total of 30 products, the first Prix Galien Russia can already be called a success. Frédéric
Boucheseiche, General Secretary of the Prix Galien Russia, said of the turnout, “this really
exceeds our expectations, and we would like to thank all the participants for their support. We
are more than happy about both the number and quality of the applications we are receiving,
and the enthusiasm shown by pharmaceutical companies for the first national committee of
the Prix Galien.”
The winners will be announced at the Gala dinner, to take place at the SwissÔtel convention
center in Moscow on the 24th
of October 2013.
Sponsored by:
For the special Prize for Research in Russia, Oncomax and Metamax—two companies backed
by Maxwell Biotech Group, an RVC investment fund—have already confirmed their
participation. So have Mitotech, a company backed by Rusnano and Generium.
Applications in this category will be accepted until the end of June. The Prize is open to
academia, health care institutions, research centers, and companies that have been involved in
biopharmaceutical research in Russia for at least three years. Applicants must demonstrate a
substantial contribution to the diagnosis, prevention, or treatment of disease.
To apply or recommend candidates for the Special Prize, attend the Gala dinner, become a
sponsor, or for further enquiries about Prix Galien Russia, please contact Crystelle Coury at
[email protected] or log on www.prixgalienrussia.com
Prix Galien Russia partners with Cegedim
June 05, 2013
Prix Galien Russia and Cegedim have agreed to cooperate in order to keep over 500.000
medical doctors in Russia informed on the prestigious award’s development and results.
Frédéric Boucheseiche general secretary of the Prix Galien Russia declared: “with its
unrivalled access to medical doctors, Cegedim was a natural choice for the Prix Galien
Russia. We are happy to have such a partner in order to keep a very large amount of medical
doctors in Russia informed about the results of the Prix Galien Russia different awards
category. We believe that no other company has such a privileged access to medical doctors
in Russia.”
Lucia Railean, Managing Director of Cegedim emphasized: “Prix Galien brings recognition to
the effort of pharmaceutical companies and researchers to improve the life of patients in
Russia and around the World. According to ROSSTAT data, between 2006-2011, only 4-7%
innovative drugs consumed in Russia were manufactured locally. The government targets to
bring this figure to 50% by 2020. This requires common efforts by all stakeholders to boost
R&D in Russia. In this regards, the Prix Galien comes at the right moment for Russia,
reminding us of the crucial role played by biopharmaceutical research to save lives. Cegedim
Russia is proud to be associated to this initiative.”
Organized for the first time in Moscow in 2013, the 9 eminent members of the independent
scientific selection committee of the Prix Galien Russia will nominate one winner in each of
the following categories: Best Pharmaceutical Agent, Best Biotechnology Product , Best
Research in Russia.
14 multinational biopharmaceutical companies have confirmed their participation. Abbvie,
Amgen, Astra Zeneca, Bayer, BMS, Boehringer Ingelheim, Janssen Pharmaceutica, Lilly,
Sponsored by:
Merck, MSD, Novartis, Roche, Servier and Takeda will all submit 30 products to the
following Jury:
Prof. Alexander Grigorievich Chuchalin (Chairman): Director FSI Pulmonogy Research
Institute. Academician of the RAMS
Prof. Sergey Olegovich Bachurin: Titular Member of the Division of “Chemistry and
Human Health” of the IUPAC and the Vice-Chairman of the Russian Society for Medicinal
Chemistry.
Prof. Vladimir Trofimovich Ivashkin: President of Russian Gastroenterological
Association. Academician of the RAMS
Prof. Eugeny Lvovich Nasonov: Director of Research Institute of Rheumatology
Prof. Rem Viktorovich Petrov: Vice President of the Russian Academy of Sciences
Prof. Dmitry Yurievich Pushkar: Chief Urologist Ministry of Health and Social
development of the RF
Prof. Gennady Tikhonovich Sukhikh: Director FSI Obstetrics, Gynecology and
Neonatology Institute
Prof. Evgeny Davidovich Sverdlov: Head of the Genetics and Postgenomic Technologies
Dpt of the Shemyakin-Ovchinnikov Institute of Bioorganic
Prof. Vsevolod Arsenievich Tkachuk: Dean of Faculty of Fundamental Medicine M.V.
Lomonosov State University
Prof. Michael Veniaminovich Ugrumov (Vice Chairman) – Head of the Laboratory of
Hormonal Regulations of the Institute of Developmental Biology of the RAS
The laureates will be receiving a medal during a gala dinner on the 24th
of October at
SwissÔtel Moscow Convention center.
Around the world the prix Galien is considered highest accolade for the biopharmaceutical
pharmaceutical industry and often compared to the Nobel prize for the industry.
For more information about the Prix Galien Russia log onto: www.prixgalienrussia.com or
contact Crystelle Coury : [email protected]
Sponsored by:
Prix Galien Russia Officially Launched
February 22, 2013
A VIP cocktail reception announcing the first Prix Galien Russia was hosted by Monsieur
Jean de Gliniasty, Ambassador of France to the Russian Federation and Frédéric
Boucheseiche, General Secretary of the Prix Galien Russia. The reception was held on
February 7 at the Igumnov House – was built in 1883 – 1893 to the design by Nikolay
Pozdeyev , residence of the French Ambassadors to Russia since 1979.
This reception marked the official launch of the Prix Galien Russia, which is set to quickly
become the highlight of the year underscoring innovation in the pharmaceutical industry in
Russia.
Globally, the Galien Award is the most coveted award for the pharmaceutical industry and
often regarded as the Nobel Prize for innovation in life sciences and biopharmaceutical
research. Founded over 40 years ago in France, there are now 16 countries organizing a
national Galien Prize. Russia is the latest country to join the list of organizing nations. Every
two years, laureate recipients of national awards compete in a global competition, The Prix
Galien International.
The event was attended by over 60 VIP guests including academicians and eminent scientists,
decision makers of the pharmaceutical industry.
After an introductory speech by the Ambassador and the General Secretary, the selection
committee was unveiled:
Prof. Alexander Grigorievich Chuchalin (Chairman of the committee)
Prof. Sergey Olegovich Bachurin
Prof. Vladimir Trofimovich Ivashkin
Prof. Eugeny Lvovich Nasonov
Prof. Rem Viktorovich Petrov
Prof. Dmitry Yurievich Pushkar
Prof. GennadyTikhonovich Sukhikh
Prof. Evgeny Davidovich Sverdlov
Prof. Michael Veniaminovich Ugrumov (Vice Chairman of the committee)
Sponsored by:
The selection committee is completely independent in the judging process and its decisions
are final. The Jury will select finalists in the following categories: Best Pharmaceutical Agent
(i.e. small molecule), Best Biotechnology Product .
The prizes will be awarded principally based on two criteria:
- What was innovative in the course of this product’s scientific development, application
or clinical utility?
- What was learned for the future of biomedical science from this product’s introduction
to the clinic?
Criteria that will NOT be considered are the size of the market, the size of the company, the
cost of development or the contingencies of distribution.
In addition, a special Prize named the “Prix Galien Russia – Research” will be awarded to the
researcher or the research team judged by the Selection Committee to have made the most
significant contribution to bio-pharmaceutical research in Russia.
The winners of each category will receive the prestigious commemorative Prix Galien Medal
in a gala dinner and awards ceremony in Moscow on October 24th, 2013. Over 200 guests,
including many academic, industry and government luminaries are expected to attend.
Photos of the event are available here
Russian transcripts of the speeches are available here
Russian translation of the letter of support of the Galien International Committee is available
here
For more information about the Prix Galien Russia 2013 you can log on
www.prixgalienrussia.com or contact [email protected] .
Prix Galien Russia selection committee to be announced on February 7,
2013
January 29, 2013
For the past 40 years, the Prix Galien has rewarded excellence in life sciences research and
innovation. It is often considered the Nobel of the pharmaceutical industry. Present with
national awards committees in over 15 countries around the World, the Prix Galien is finally
coming to Russia.
Sponsored by:
For the first time, on October 24, 2013, the Prix Galien Russia awards will be organized in
Moscow and an independent selection committee composed of eminent scientists of the
Russian Federation will announce a winner in each of the following categories:
- Best pharmaceutical agent
- Best Biotechnological product
- Prix Galien – Best research in Russia
Jean de Gliniasty, French Ambassador to Russia, and Focus Reports will co-host an
inauguration cocktail to officially launch the Prix Galien Russia. This ceremony will take
place at the Residence of the Ambassador, in Moscow on the February 7, 2013. During this
cocktail the Secretary General will announce the Prix Galien Russia selection committee.
For more information about application or sponsorship opportunities click here